Tim Brighton

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): a pooled subgroup analysis of two randomised controlled trials

Martin H. Prins, Anthonie W.A. Lensing, Tim Brighton et al. · The Lancet Haematology · 2014 · 282 citations

Pooled Subgroup Analysis, Thrombosis, Venous Thrombosis +14

Plasma P-selectin is increased in thrombotic consumptive platelet disorders

BH Chong, B Murray, MC Berndt et al. · Blood · 1994 · 250 citations · Full text

Recommendations for the diagnosis and treatment of deep venous thrombosis and pulmonary embolism in pregnancy and the postpartum period

Claire McLintock, Tim Brighton, Sanjeev Chunilal et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 2011 · 122 citations

Impaired Thrombin Generation in β2-Glycoprotein I Null Mice

Yonghua Sheng, Stephen Reddel, Herbert Herzog et al. · Journal of Biological Chemistry · 2001 · 89 citations · Full text

Recommendations for the prevention of pregnancy‐associated venous thromboembolism

Claire McLintock, Tim Brighton, Sanjeev Chunilal et al. · Australian and New Zealand Journal of Obstetrics and Gynaecology · 2011 · 83 citations

Thrombosis, Venous Thrombosis, Abortion +15